Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain (Q24794765)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q295691)
(Q28025149)
(Q37621431)
(P275) (Q20007257)
(P304) e73
(P407) (Q1860)
(P433) 3
(P478) 2
(P577) +2005-03-00T00:00:00Z
(P921) (Q356033)
(Q418369)
(P1433) (Q1686921)
(P1476) "Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain" (language: en)
(P2093) Vincent A Miller
Katerina A Politi
Gregory J Riely
Romel Somwar
Maureen F Zakowski
(P2860) (Q21563446)
(Q24561953)
(Q27639528)
(Q27824812)
(Q27824793)
(Q27861059)
(Q28282744)
(Q28274882)
(Q29615030)
(Q29618788)
(Q30014844)
(Q35993288)
(Q35968384)
(Q35953128)
(Q40502745)
(Q34345063)
(Q34333693)
(Q34331384)
(Q38355628)
(Q40669638)
(Q34131272)
(Q45190258)
(Q45205054)
(Q44906233)
(Q44743780)
(Q72240453)
(Q58024134)
(P6216) (Q50423863)
other details